LOS ANGELES--(Business WIRE)--Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical organization, declared the poster presentation of a Phase I/II demo of...
Presentation
Late-breaking poster presentation to highlight preclinical data demonstrating that the increased potency of CD8-targeted fusosomes enhances CAR gene delivery to...